COVID-19 and Intensive Care

IF 0.3 Q4 ALLERGY Astim Allerji Immunoloji Pub Date : 2020-09-23 DOI:10.21911/AAI.555
L. Talan, N. D. Altıntaş
{"title":"COVID-19 and Intensive Care","authors":"L. Talan, N. D. Altıntaş","doi":"10.21911/AAI.555","DOIUrl":null,"url":null,"abstract":"COVID-19 caused by SARS-CoV2 has spread rapidly across the world, resulting in many patients in need of intensive care support Severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis/septic shock, and multi-organ failure may occur during the disease course among many other complications There still is not a definite cure, but supportive care is important to minimize complications Patients in need of respiratory support and interventions should preferably be placed in negative pressure isolation rooms, with utmost care to decrease viral spread Points to consider during oxygen therapy, non-invasive and invasive mechanical ventilation, and shock management of COVID-19 patients are discussed Patients with mild hypoxia may be managed with conventional oxygen therapy, while others will benefit from high flow nasal oxygen therapy and mechanical ventilation Although corticosteroids are not recommended for other viral pneumonia, there are recent reports suggesting that steroids may have a place in the treatment of COVID-19 patients with hypoxia Shock may complicate the course of the disease and a search for the etiology of shock should be carefully planned Thromboembolic events are common;prophylaxis and/or treatment of thromboembolic events should be managed according to the guidelines Meanwhile, the results of ongoing randomized, controlled trials on antiviral and immunomodulatory agents are expected to offer better treatment options for COVID-19 patients in the near future","PeriodicalId":42004,"journal":{"name":"Astim Allerji Immunoloji","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2020-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Astim Allerji Immunoloji","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21911/AAI.555","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 2

Abstract

COVID-19 caused by SARS-CoV2 has spread rapidly across the world, resulting in many patients in need of intensive care support Severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis/septic shock, and multi-organ failure may occur during the disease course among many other complications There still is not a definite cure, but supportive care is important to minimize complications Patients in need of respiratory support and interventions should preferably be placed in negative pressure isolation rooms, with utmost care to decrease viral spread Points to consider during oxygen therapy, non-invasive and invasive mechanical ventilation, and shock management of COVID-19 patients are discussed Patients with mild hypoxia may be managed with conventional oxygen therapy, while others will benefit from high flow nasal oxygen therapy and mechanical ventilation Although corticosteroids are not recommended for other viral pneumonia, there are recent reports suggesting that steroids may have a place in the treatment of COVID-19 patients with hypoxia Shock may complicate the course of the disease and a search for the etiology of shock should be carefully planned Thromboembolic events are common;prophylaxis and/or treatment of thromboembolic events should be managed according to the guidelines Meanwhile, the results of ongoing randomized, controlled trials on antiviral and immunomodulatory agents are expected to offer better treatment options for COVID-19 patients in the near future
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19和重症监护
由SARS-CoV2引起的COVID-19在全球范围内迅速传播,导致许多患者需要重症监护支持,在病程中可能出现严重肺炎、急性呼吸窘迫综合征(ARDS)、败血症/感染性休克、多器官衰竭等并发症,目前仍没有明确的治愈方法。需要呼吸支持和干预措施的患者最好放置在负压隔离室,并尽可能小心减少病毒传播,讨论了在氧疗、无创和有创机械通气以及COVID-19患者休克管理过程中需要考虑的要点。虽然皮质类固醇不推荐用于其他病毒性肺炎,最近的报告显示,类固醇可能在治疗COVID-19患者中发挥作用,但缺氧休克可能使病程复杂化,休克病因的研究应仔细规划。血栓栓塞事件很常见,血栓栓塞事件的预防和/或治疗应根据指南进行管理。抗病毒和免疫调节剂的对照试验有望在不久的将来为COVID-19患者提供更好的治疗选择
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
10
期刊介绍: Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English. The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal. The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.
期刊最新文献
Delayed Urticaria- Angioedema After mRNA Vaccine in an Adolescent Patient: Case Report A Father and Son Diagnosed with DiGeorge Syndrome DRESS Syndrome due to Carbamazepine Use in A Drug-Addicted Adolescent FROM THE EDITOR Identification of Novel Endochitinase Class I Based Allergens
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1